Objective. To measure, and seek clinical correlates with, levels of substance P (SP) in the cerebrospinal fluid (CSF) of fibromyalgia syndrome (FMS) patients.Methods. CSF from 32 FMS patients and 30 normal control subjects was tested for SP by radioimmunoassay . Clinical measures included tender point examination and standardized questionnaires.Results. CSF SP levels were 3-fold higher in FMS patients than in normal controls (P < 0.001), but they correlated only weakly with tenderness found on examination.
Concfusion. SP is significantly elevated in FMS CSF, but other abnormalities must exist in FMS to more fully explain the symptoms.Fibromyalgia syndrome (FMS) is a chronic, painful, musculoskeletal disorder commonly seen in rheumatology practice (14). Prevalence studies in Norway, Denmark, Germany, and South Africa have shown that 3-10% of the general population is affected, which would make FMS more common than rheumatoid arthritis (5). The comparison with rheumatoid arthritis is pertinent because the severity of the
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.